James E. Foley

At SMART Biosciences they are engaged in a coordinated effort to discover and develop novel small-molecule therapeutics to treat major age-related illnesses, including Alzheimer's disease and various forms of cancer. Since its beginning in 2005, as a spin-off of Columbia University, they have been working to address significant unmet therapeutic needs in these large and rapidly growing markets. Through its affiliation with Columbia University, SMART holds exclusive worldwide licenses to valuable intellectual property. Its scientists have identified several novel targets in two therapeutic areas that have the potential for new treatments in: Alzheimer's disease--a novel lipid target that modulates levels of neurotoxic beta-amyloid in the brain, Cancer--novel targets that modulate p53 stability, increasing tumor-cell sensitivity to cytotoxic and radiation therapies. They believe its intellectual property and scientific rationale for future compound discovery offers a compelling opportunity for commercialization. SMART is led by management and scientific advisory teams comprised of preeminent professionals distinguished in the worlds of academic science, pharmaceutical discovery, business/corporate development, finance and intellectual property law. The SMART Biosciences leadership team brings scientific rigor, business leadership, and innovation experience to its endeavors. Its discovery and development strategy employs a unique-to-the-industry collaborative network of advanced business, academic and R&D interests throughout the United States and Asia.

New York Pharma Forum, Inc. provides information technology services for the healthcare industry. The private company is based in New York, NY.

Japan America Society of Greater Philadelphia is a private nonprofit organization that has been promoting mutual curiosity, understanding, and collaboration between Japan and America for over 30 years through art, business, and culture. The private company is based in Philadelphia, PA. The company operates the Shofuso Japanese House and Garden and produce the Subaru Cherry Blossom Festival.

Part of Triton Advisers Ltd., Traxion BV is a Dutch company that specializes in providing flexible solutions for Identity and Access Management. The company is based in Waardenburg, Netherlands. The company offers consultancy and services to work towards robust and flexible security solutions. Traxion was founded in 2000 by Erik de Jong, Evert van den Branden, John van Westeneng, and Evert van den Branden has been the CEO since then. Traxion was acquired by Swiss IT Security AG, part of Triton Advisers Ltd. from October 22, 2021 on March 09, 2021.

Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom.

SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA.

Part of Sosei Group Corp., Sosei Co. Ltd. is a world-leader in GPCR medicine design and development. The company is based in Tokyo, Japan. The Japanese company obtains and maintains intellectual property rights to protect its innovations and technologies.